Erasca CMO Exercises Options, Sells All Direct Stock Holdings for $301,000.

Erasca CMO Morris Shannon sold 20,000 shares of Common Stock for $301,000 on March 4, 2026, reducing his direct Common Stock holdings to zero. The transaction involved exercising options and immediately selling the shares. Shannon still holds rights to acquire up to 515,800 shares through stock options. The company's products include clinical-stage oncology drug candidates targeting the RAS/MAPK pathway.